‘The Modern-Day Version of Agent Orange’: Hoffmann-La Roche, Genentech Hit with Class Action Over Antimalarial Drug
January 3, 2022 Hoffmann-La Roche and Genentech face a class action over their alleged failure to warn U.S. military service members of the “substantial and irreversible” dangers of the antimalarial drug mefloquine.